136 related articles for article (PubMed ID: 28899779)
1. Eupatilin with PPARα agonistic effects inhibits TNFα-induced MMP signaling in HaCaT cells.
Jung Y; Kim JC; Choi Y; Lee S; Kang KS; Kim YK; Kim SN
Biochem Biophys Res Commun; 2017 Nov; 493(1):220-226. PubMed ID: 28899779
[TBL] [Abstract][Full Text] [Related]
2. Sargahydroquinoic acid inhibits TNFα-induced AP-1 and NF-κB signaling in HaCaT cells through PPARα activation.
Jeon Y; Jung Y; Kim MC; Kwon HC; Kang KS; Kim YK; Kim SN
Biochem Biophys Res Commun; 2014 Aug; 450(4):1553-9. PubMed ID: 25019995
[TBL] [Abstract][Full Text] [Related]
3. Abietic acid inhibits UVB-induced MMP-1 expression in human dermal fibroblast cells through PPARα/γ dual activation.
Jeon Y; Jung Y; Youm JK; Kang KS; Kim YK; Kim SN
Exp Dermatol; 2015 Feb; 24(2):140-5. PubMed ID: 25496486
[TBL] [Abstract][Full Text] [Related]
4. 5,7-Dimethoxyflavone, an activator of PPARα/γ, inhibits UVB-induced MMP expression in human skin fibroblast cells.
Kim JK; Mun S; Kim MS; Kim MB; Sa BK; Hwang JK
Exp Dermatol; 2012 Mar; 21(3):211-6. PubMed ID: 22379967
[TBL] [Abstract][Full Text] [Related]
5. Eupatilin, an activator of PPARα, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice.
Jung Y; Kim JC; Park NJ; Bong SK; Lee S; Jegal H; Jin LT; Kim SM; Kim YK; Kim SN
Biochem Biophys Res Commun; 2018 Feb; 496(2):508-514. PubMed ID: 29353040
[TBL] [Abstract][Full Text] [Related]
6. The flavone eupatilin inhibits eotaxin expression in an NF-κB-dependent and STAT6-independent manner.
Jeon JI; Ko SH; Kim YJ; Choi SM; Kang KK; Kim H; Yoon HJ; Kim JM
Scand J Immunol; 2015 Mar; 81(3):166-76. PubMed ID: 25565108
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells.
Park BB; Yoon Js; Kim Es; Choi J; Won Yw; Choi Jh; Lee YY
Tumour Biol; 2013 Apr; 34(2):875-85. PubMed ID: 23292941
[TBL] [Abstract][Full Text] [Related]
8. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
10. Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats.
Xiong D; Deng Y; Huang B; Yin C; Liu B; Shi J; Gong Q
Int Immunopharmacol; 2016 Jan; 30():157-162. PubMed ID: 26679678
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid inhibits TNF-alpha-induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells.
Kim HH; Lee Y; Eun HC; Chung JH
Biochem Biophys Res Commun; 2008 Apr; 368(2):343-9. PubMed ID: 18222174
[TBL] [Abstract][Full Text] [Related]
13. A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells.
Zhao Y; Yan L; Luo XM; Peng L; Guo H; Jing Z; Yang LC; Hu R; Wang X; Huang XF; Wang YQ; Jin X
Eur J Pharmacol; 2016 Oct; 788():104-112. PubMed ID: 27318324
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
15. Eupatilin inhibits H(2)O(2)-induced apoptotic cell death through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB.
Lee S; Lee M; Kim SH
Food Chem Toxicol; 2008 Aug; 46(8):2865-70. PubMed ID: 18603343
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.
Mogilenko DA; Kudriavtsev IV; Shavva VS; Dizhe EB; Vilenskaya EG; Efremov AM; Perevozchikov AP; Orlov SV
J Biol Chem; 2013 Jan; 288(3):1726-38. PubMed ID: 23168409
[TBL] [Abstract][Full Text] [Related]
17. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
[TBL] [Abstract][Full Text] [Related]
18. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator activated receptor-α agonists suppress transforming growth factor-α-induced matrix metalloproteinase-9 expression in human keratinocytes.
Meissner M; Berlinski B; Gille J; Doll M; Kaufmann R
Clin Exp Dermatol; 2011 Dec; 36(8):911-4. PubMed ID: 21790722
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
